Yazar "Bar, Jair" seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met-overexpressing (OE) advanced non-small cell lung cancer (NSCLC).(Lippincott Williams & Wilkins, 2022) Camidge, D. Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan W.; Moiseenko, Fedor Vladimirovich; Filippova, Elena; Cicin, Irfan[Abstract Not Available]Öğe Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.(Amer Assoc Cancer Research, 2021) Camidge, D. Ross; Moiseenko, Fedor; Cicin, Irfan; Horinouchi, Hidehito; Filippova, Elena; Bar, Jair; Lu, Shun[Abstract Not Available]Öğe Telisotuzumab vedotin monotherapy in Asian patients with c-Meteoverexpressing advanced non-small cell lung cancer(Elsevier, 2023) Horinouchi, Hidehito; Camidge, D. Ross; Bar, Jair; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan[Abstract Not Available]
